ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2608

The “Rheumatoid Arthritis Impact of Disease”� Score Correlates with Other Patient Reported Outcomes and with Disease Activity Scores in Patients with RA and Its Patient Acceptable Symptom State Is More Stringent Than DAS28-Remission

Ricardo J.O. Ferreira1,2, Cátia Duarte1,3, Sylvie Batista3, Catarina Medeiros3, J.P. Sousa3, Gisela Eugénio1, Carlos Costa1, Pedro Carvalho1, Joana F. Ferreira1, Margarida Coutinho1,4, Maria J. Salvador1,4, Laure Gossec5 and J.A.P. da Silva3,6, 1Rheumatology, Centro Hospitalar e Universitário de Coimbra - Hospitais da Universidade de Coimbra, EPE, Coimbra, Portugal, 2Health Sciences Research Unit: Nursing (UICISA: E), Coimbra, Portugal, 3Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal, 4Clínica Universitária de Reumatologia, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal, 5Rheumatology, Pitié Salpetriere Hospital, Paris, France, 6Centro Hospitalar e Universitário de Coimbra - Hospitais da Universidade de Coimbra, EPE, Coimbra, Portugal

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity, doctor-patient relationship, patient-reported outcome measures, remission and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The “Rheumatoid Arthritis Impact of Disease” (RAID)
score is a Patient Reported Outcome (PRO) that comprises seven domains of disease[1], that may reflect the patient’s perspective more
widely than other PROs. A cut-off corresponding to
the patient acceptable symptom state (PASS) has been defined as RAID score <=2
[2]. This study aims: 1) to
assess the associations between the RAID and established measures used in RA
(disease activity measures and other PROs); 2) to analyse the relationship
between clinical remission and PASS by RAID.

Methods: Consecutive
RA patients
(ACR/EULAR 2010 or ACR 1987 criteria) followed in a tertiary rheumatology
department were included in this cross-sectional study. Patient demographics
and clinical data collected were: DAS28, SDAI, CDAI and HAQ; patient and
physician global assessment (PGA and PhGA); the Hospital Anxiety and Depression Scale (HADS), the
Happiness Scale (HS) and the EuroQOL (EQ5D) score.
RAID and DAS28 (4vCRP) scores were classified according to PASS and remission
definitions (<=2 and <=2.6, respectively). We used Spearman correlation
coefficient, Qui-square and Kappa as statistic tests.

Results: 101
patients were included (82% females, 58.8±12.4 years and 13.0±8.6 years of
disease duration). Disease impact and activity were moderate: mean RAID=4.8±2.2
and mean DAS28(4vCRP)=2.9±1.2. RAID showed moderate
correlations with most of the established combined indices of disease activity,
with the HAQ having the highest correlation (r=0.66). Regarding other PROs,
RAID was strongly correlated with PGA (r=0.70) and moderately with the
remaining (Table 1).

Out of 50 patients in DAS28
remission, 11 had a RAID score consistent with PASS but 39 had higher scores.
Of the 51 patients not in remission, only one patient had a RAID score
consistent with PASS (Table 2). This difference of proportions was
statistically significant (
X2(1)=9.684; p=0.002; Kappa=0.20).

Conclusion: RAID
correlates well with different PROs and moderately with disease activity
scores. Its use in clinical practice may allow a better representation of the
global impact of RA in patient’s lives.

As disease remission by DAS and
PASS by RAID are in disagreement for a considerable percentage of patients,
further research on this topic is warranted.

References:

1. Gossec
L, et al. Ann Rheum Dis 2011;70(6):935-42.


2. Dougados
M, et al. Arth Res & Ther
2012;14(3):R129.


Disclosure: R. J. O. Ferreira, None; C. Duarte, None; S. Batista, None; C. Medeiros, None; J. P. Sousa, None; G. Eugénio, None; C. Costa, None; P. Carvalho, None; J. F. Ferreira, None; M. Coutinho, None; M. J. Salvador, None; L. Gossec, None; J. A. P. da Silva, None.

To cite this abstract in AMA style:

Ferreira RJO, Duarte C, Batista S, Medeiros C, Sousa JP, Eugénio G, Costa C, Carvalho P, Ferreira JF, Coutinho M, Salvador MJ, Gossec L, da Silva JAP. The “Rheumatoid Arthritis Impact of Disease”� Score Correlates with Other Patient Reported Outcomes and with Disease Activity Scores in Patients with RA and Its Patient Acceptable Symptom State Is More Stringent Than DAS28-Remission [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-rheumatoid-arthritis-impact-of-disease%ef%bf%bd-score-correlates-with-other-patient-reported-outcomes-and-with-disease-activity-scores-in-patients-with-ra-and-its-patient-acceptable-symptom-stat/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-rheumatoid-arthritis-impact-of-disease%ef%bf%bd-score-correlates-with-other-patient-reported-outcomes-and-with-disease-activity-scores-in-patients-with-ra-and-its-patient-acceptable-symptom-stat/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology